Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05414396

Eat, Move, Live Program for the Reduction of Cancer and Chronic Disease Risk in Underserved Communities

This clinical trial tests the Eat, Move, Live (EML) Program in reducing the risk of chronic diseases among underserved communities by improving healthy lifestyle practices, increasing physical activity and encouraging healthy eating behaviors. EML is a series of free culturally and linguistically appropriate nutrition and physical activity sessions. The interactive education segment of the EML Program is culturally responsive, and based on the community EML program, and topics will include: nutrition guidelines, reading food labels, recipe modification and healthy food preparation, eating healthy on a budget, chronic diseases information and prevention strategies. The EML program may help reduce the risk of cancer and chronic diseases by encouraging more physical activity and healthy eating behaviors.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

City of Hope Medical Center

Duarte, California, 91010, United States

About this study

PRIMARY OBJECTIVES:

I. To evaluate program by assessing in combination with standard of care metformin: Changes in participants' knowledge, attitudes, and behavior.

II. To evaluate program by assessing in combination with standard of care metformin: Changes in body measurements.

III. To evaluate program by assessing in combination with standard of care metformin: Changes in biomarkers.

OUTLINE:

Participants attend EML program sessions weekly for 12 weeks including an educational session chronic disease risk reduction via nutrition and physical activity, a physical activity session, and a cooking/taste test demonstration.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Agrees to group consent at week 1
  • Age over 18
  • Able to speak and understand English and/or Spanish

Exclusion criteria

  • Don't agree to group consent at week 1
  • Age younger than 18
  • Not able to speak and understand English and/or Spanish
  • Can't participate in physical activity

Treatment and study plan

behavioral intervention

Behavioral

Attend EML program sessions

Other names: Behavior Conditioning Therapy, Behavior Modification, Behavior or Life Style Modifications, Behavior Therapy, Behavioral Interventions, Behavioral Modification, Behavioral Therapy, Behavioral Treatment, Behavioral Treatments

Questionnaire Administration

Other

Ancillary studies

Primary outcomes

  1. Changes in attitudes and beliefs as measured by questionnaires from baseline to week 12

    Time frame: Baseline and week 12

    Attitudes and beliefs regarding causes of diabetes asked in questionnaire, measured by endorsing one of the Likert-type scale values ranging from 1 (Agree) to 7 (Disagree).

  2. Changes in behavior as measured by questionnaires from baseline to week 12

    Time frame: Baseline and week 12

    Behaviors related to food consumption asked in questionnaires, measured by endorsing one of "None", "1", "2-3", "4-6", "7 or more".

  3. Changes in height from baseline to week 12

    Time frame: Baseline to 12 weeks

    Height measured in meters

  4. Changes in weight from baseline to week 12

    Time frame: Baseline to 12 weeks

    Weight measured in Kilograms

  5. Changes in waist circumference from baseline to week 12

    Time frame: Baseline to 12 weeks

    Hip circumference measured in centimeters

  6. Changes in chest circumference from baseline to week 12

    Time frame: Baseline to 12 weeks

    Chest circumference measured in centimeters

  7. Changes in right upper arm circumference from baseline to week 12

    Time frame: Baseline to 12 weeks

    Right upper arm circumference measured in centimeters

  8. Changes in left upper arm circumference from baseline to week 12

    Time frame: Baseline to 12 weeks

    Left upper arm circumference measured in centimeters

  9. Changes in right upper thigh circumference from baseline to week 12

    Time frame: Baseline to 12 weeks

    Right upper thigh circumference measured in centimeters

  10. Changes in left upper thigh circumference from baseline to week 12

    Time frame: Baseline to 12 weeks

    Left upper thigh circumference measured in centimeters

  11. Changes in body fat percentage from baseline to week 12

    Time frame: Baseline to 12 weeks

    Body fat percentage measured in percent using a handheld BMI machine that calculates body fat percentage.

  12. Changes in systolic blood pressure from baseline to week 12

    Time frame: Baseline to 12 weeks

    Systolic blood pressure measured in mmHG

  13. Changes in diastolic blood pressure from baseline to week 12

    Time frame: Baseline to 12 weeks

    Diastolic blood pressure measured in mmHG

  14. Changes in hip circumference from baseline to week 12

    Time frame: Baseline to 12 weeks

    Hip circumference measured in centimeters

  15. Changes in biomarkers

    Time frame: Baseline to 12 weeks

    Will be collected at baseline and follow up based on glycosylated hemoglobin (A1C) measuring guidelines.

Sponsors and collaborators

Lead sponsor

City of Hope Medical Center

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Official study title

Reducing Cancer and Chronic Disease Risk in Underserved Communities: Eat, Move, Live Program

Important dates

Study start
2018
Primary completion
2026
Study completion
2026
First posted
Jun 10, 2022
Registry last updated
Dec 5, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.